Stay updated with breaking news from Nyse Ebs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Emergent BioSolutions Inc. (NYSE:EBS – Get Rating) have received a consensus recommendation of “Hold” from the eight research firms that are covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a sell recommendation, one has given a hold recommendation and two have given a buy recommendation to the company. […]
Emergent BioSolutions Inc. (NYSE:EBS – Get Rating) saw a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 7,600,000 shares, an increase of 22.4% from the March 15th total of 6,210,000 shares. Approximately 18.7% of the company’s shares are sold short. Based on an average […]
Benchmark upgraded shares of Emergent BioSolutions (NYSE:EBS – Get Rating) from a hold rating to a buy rating in a report released on Monday morning, The Fly reports. Benchmark currently has $22.00 price target on the biopharmaceutical company’s stock. EBS has been the subject of a number of other research reports. TheStreet lowered Emergent BioSolutions […]
Benchmark upgraded shares of Emergent BioSolutions (NYSE:EBS – Get Rating) from a hold rating to a buy rating in a report released on Monday, The Fly reports. Benchmark currently has $22.00 target price on the biopharmaceutical company’s stock. Several other analysts have also weighed in on EBS. TheStreet lowered Emergent BioSolutions from a c- rating […]
Emergent BioSolutions Inc. (NYSE:EBS – Get Rating) gapped down before the market opened on Tuesday after the company announced weaker than expected quarterly earnings. The stock had previously closed at $14.00, but opened at $13.27. Emergent BioSolutions shares last traded at $12.15, with a volume of 395,192 shares traded. The biopharmaceutical company reported ($0.31) earnings […]